Novartis Files Suit To Stop Chinese Entresto Generic

By Elliot Weld · April 12, 2023, 5:29 PM EDT

Swiss pharmaceutical giant Novartis AG filed a patent infringement suit Monday claiming China's Nanjing Noratech Pharmaceutical Co. is attempting to manufacture and distribute a generic version of the heart medication Entresto...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novartis Pharmaceuticals Corporation v. Nanjing Noratech Pharmaceutical Co., Limited

Case Number

1:23-cv-00401

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

April 10, 2023